Literature DB >> 20173670

A natural course of main duct intraductal papillary mucinous neoplasm of the pancreas with lower likelihood of malignancy.

Hiroyuki Uehara1, Osamu Ishikawa, Kenji Ikezawa, Natsuko Kawada, Takuya Inoue, Rena Takakura, Yasuna Takano, Sachiko Tanaka, Akemi Takenaka.   

Abstract

OBJECTIVES: Main duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas include neoplasms with varying likelihood of progression to malignancy. The aim of this study was to investigate a natural course of main duct IPMNs with a lower likelihood of malignancy.
METHODS: Twenty main duct IPMNs with a lower likelihood of malignancy, which was defined as mural nodule of less than 10 mm or no visualized mural nodule, and negative result of cytological examination of pancreatic juice, underwent regular ultrasound every 3 months. Special imaging examinations and additional pancreatic juice cytological examination were performed when necessary. Surgery was considered when a mural nodule enlarged to 10 mm or the cytological examination result indicated malignancy.
RESULTS: During a mean of 70 months, 12 IPMNs (60%) did not progress and 6 (30%) progressed within a lower likelihood of malignancy. The remaining 2 IPMNs (10%) progressed to meet the criteria for resection, underwent surgery, and were demonstrated to be carcinomas.
CONCLUSIONS: Main duct IPMN with a lower likelihood of malignancy was divided into 2 subgroups: neoplasm that progressed and that which did not progress during its natural course. The former should be resected considering its malignant potential, whereas the latter may be managed nonsurgically as long as it stays unchanged.

Entities:  

Mesh:

Year:  2010        PMID: 20173670     DOI: 10.1097/MPA.0b013e3181c81b52

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  7 in total

Review 1.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 2.  Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas.

Authors:  S Nougaret; L Mannelli; M-A Pierredon; V Schembri; B Guiu
Journal:  Diagn Interv Imaging       Date:  2016-11-11       Impact factor: 4.026

3.  Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Mathieu Daudé; Fabrice Muscari; Camille Buscail; Nicolas Carrère; Philippe Otal; Janick Selves; Louis Buscail; Barbara Bournet
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN.

Authors:  Takehiro Okabayashi; Yasuo Shima; Takuhiro Kosaki; Tatsuaki Sumiyoshi; Akihito Kozuki; Tastuo Iiyama; Yuka Takezaki; Michiya Kobayashi; Isao Nishimori; Yasuhiro Ogawa; Kazuhiro Hanazaki
Journal:  Oncol Lett       Date:  2013-03-21       Impact factor: 2.967

Review 5.  Intraductal papillary mucinous neoplasm of the pancreas: an update.

Authors:  Shu-Yuan Xiao
Journal:  Scientifica (Cairo)       Date:  2012-11-28

6.  Duodenum and ventral pancreas preserving subtotal pancreatectomy for low-grade malignant neoplasms of the pancreas: An alternative procedure to total pancreatectomy for low-grade pancreatic neoplasms.

Authors:  Xing Wang; Chun-Lu Tan; Hai-Yu Song; Qiang Yao; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

Review 7.  The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Simone Serafini; Cosimo Sperti; Alessandra Rosalba Brazzale; Diego Cecchin; Pietro Zucchetta; Elisa Sefora Pierobon; Alberto Ponzoni; Michele Valmasoni; Lucia Moletta
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.